Lobbying in D.C. with Americans for Safe Access at the 2019 Unity Conference

By | April 2, 2019

The Americans for Safe Access 2019 Unity Conference, themed The Price of Being a Medical Cannabis Patient, featured over a hundred patients from all over America visiting their representatives in Congress and the Senate to promote the Medical Cannabis Control Act of 2019.

There are numerous legislative proposals in the current 116th Congress that seek to deschedule or reschedule cannabis from the Controlled Substances Act, but what happens after that? At least five federal agencies currently have juristiction when it comes to cannabis policy; The DOJ, the DEA, the FDA, the Office of National Drug Control Policy, and, the Department of Health and Human Services. What is going to happen when cannabis policy changes occur at the federal level? Which agency will have authority over medical cannabis policy? Will they all continue to play a role, as they have in the past?

Source: http://www.safeaccessnow.org/lobbying_in_d_c_with_americans_for_safe_access_at_the_2019_unity_conference

Leave a Reply

Your email address will not be published. Required fields are marked *